OBJECTIVE: Many factors may contribute to medication nonadherence in heart failure (HF), but no standard measure exists to evaluate factors associated with nonadherence. To fill this gap, we developed the Medication Adherence Scale (MAS) and tested its reliability and validity in patients with HF. METHOD: Questionnaire data were collected from 100 patients with HF at baseline using the MAS, and objective adherence data were collected for 3 consecutive months using the Medication Event Monitoring System. RESULTS: Principal component analysis yielded three factors that explained 63% of the variance in medication adherence: knowledge, attitudes, and barriers to medication adherence. Cronbach's alphas for these subscales ranged from .75 to .94, which supported their internal consistency. The Spearman rho correlation coefficients between the Medication Event Monitoring System and Knowledge, Attitudes, and Barriers scores were .25 to .31 (P < .05), demonstrating support for construct validity. CONCLUSION: These results support the reliability and validity of the MAS as a measure of knowledge, attitudes, and barriers of medication adherence.
OBJECTIVE: Many factors may contribute to medication nonadherence in heart failure (HF), but no standard measure exists to evaluate factors associated with nonadherence. To fill this gap, we developed the Medication Adherence Scale (MAS) and tested its reliability and validity in patients with HF. METHOD: Questionnaire data were collected from 100 patients with HF at baseline using the MAS, and objective adherence data were collected for 3 consecutive months using the Medication Event Monitoring System. RESULTS: Principal component analysis yielded three factors that explained 63% of the variance in medication adherence: knowledge, attitudes, and barriers to medication adherence. Cronbach's alphas for these subscales ranged from .75 to .94, which supported their internal consistency. The Spearman rho correlation coefficients between the Medication Event Monitoring System and Knowledge, Attitudes, and Barriers scores were .25 to .31 (P < .05), demonstrating support for construct validity. CONCLUSION: These results support the reliability and validity of the MAS as a measure of knowledge, attitudes, and barriers of medication adherence.
Authors: Jacqueline Dunbar-Jacob; Patricia Bohachick; Mary Kay Mortimer; Susan M Sereika; Susan M Foley Journal: J Cardiovasc Nurs Date: 2003 Jul-Aug Impact factor: 2.083
Authors: Marcel L Bouvy; Eibert R Heerdink; John Urquhart; Diederick E Grobbee; Arno W Hoes; Hubert G M Leufkens; Arno W Hoe Journal: J Card Fail Date: 2003-10 Impact factor: 5.712
Authors: Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen Journal: Transl Behav Med Date: 2015-07-09 Impact factor: 3.046
Authors: Jia-Rong Wu; Terry A Lennie; Misook L Chung; Susan K Frazier; Rebecca L Dekker; Martha J Biddle; Debra K Moser Journal: Heart Lung Date: 2011-11-03 Impact factor: 2.210
Authors: Sandra B Dunbar; Patricia C Clark; Carolyn M Reilly; Rebecca A Gary; Andrew Smith; Frances McCarty; Melinda Higgins; Daurice Grossniklaus; Nadine Kaslow; Jennifer Frediani; Carolyn Dashiff; Richard Ryan Journal: J Card Fail Date: 2013-10-29 Impact factor: 5.712
Authors: Jia-Rong Wu; Barbara Mark; George J Knafl; Sandra B Dunbar; Patricia P Chang; Darren A DeWalt Journal: Heart Lung Date: 2019-06-07 Impact factor: 2.210
Authors: Jia-Rong Wu; Terry A Lennie; Marla J De Jong; Susan K Frazier; Seongkum Heo; Misook L Chung; Debra K Moser Journal: J Card Fail Date: 2009-12-11 Impact factor: 5.712
Authors: R Oosterom-Calo; A J van Ballegooijen; C B Terwee; S J te Velde; I A Brouwer; T Jaarsma; J Brug Journal: Heart Fail Rev Date: 2013-07 Impact factor: 4.214